{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/warts-verrucae/management/management/","result":{"pageContext":{"chapter":{"id":"d04302c3-e6b8-52d5-b731-49cb72445e0b","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field d51a2e61-0629-4531-b73f-82b9768c0d82 --><h2>Scenario: Management</h2><!-- end field d51a2e61-0629-4531-b73f-82b9768c0d82 -->","summary":"Covers the management in primary care of people with warts or verrucae.","htmlStringContent":"<!-- begin item e7ba6e5d-c7e4-4e5a-ba2f-b549a4c5245c --><!-- begin field 07ff78e5-4e61-400d-ae76-acbd0088428b --><p>From age 12 months onwards.</p><!-- end field 07ff78e5-4e61-400d-ae76-acbd0088428b --><!-- end item e7ba6e5d-c7e4-4e5a-ba2f-b549a4c5245c -->","topic":{"id":"41c94fc3-84c7-5d23-b0c1-b340dde561cf","topicId":"428bb097-7256-4343-b880-fb429b718d6d","topicName":"Warts and verrucae","slug":"warts-verrucae","lastRevised":"Last revised in February 2020","chapters":[{"id":"1b91075b-35e9-580a-a349-b2aecac3712b","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"0ad476a8-9abf-5e68-8b94-60889f87963c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"0c70c378-3d0c-573b-829d-ad3fe85ba7be","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8117e71e-2ea4-540c-97dc-6f57d76c3eb9","slug":"changes","fullItemName":"Changes"},{"id":"20fb58f7-f730-5521-8a3e-e928324e4652","slug":"update","fullItemName":"Update"}]},{"id":"65d1b9d9-b162-5e9b-bfb9-98d935069c7f","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"6acab5c8-0505-5af9-8070-472e0850b28c","slug":"goals","fullItemName":"Goals"},{"id":"f5c53f23-1d42-550a-ade0-09928c029282","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4f36f273-a3e3-5263-9d17-cde56dabdabe","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6134b512-75ff-5330-9138-7c89c3f528f7","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c1fcf745-8b2c-55ba-853a-44e100100069","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"06ece2e8-1a04-508d-8f13-e45ab5493948","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"50827b1e-9574-5139-8bdd-a5cbcd82a9b8","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f4d6c184-5397-5bc0-8f52-116d518837a9","slug":"definition","fullItemName":"Definition"},{"id":"b6a55bc4-455c-5151-b02c-900fa113661c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"aa9140e4-4607-5e57-9649-d67c852e235a","slug":"transmission","fullItemName":"Transmission"},{"id":"fac43869-adf2-50c9-9628-ae77ba6e26fd","slug":"prognosis","fullItemName":"Prognosis"},{"id":"77785569-db07-55f2-ae35-34e39afe353c","slug":"complications","fullItemName":"Complications"}]},{"id":"e032a052-f3cd-51c5-8756-556955a8e37a","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"99c23bdf-3dca-5be9-900a-20a76728fcbf","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"45739bf2-ac24-500a-bf42-ebce5361bb98","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"10a2f64f-ff47-5af9-ae2f-100bfb8e7573","fullItemName":"Management","slug":"management","subChapters":[{"id":"d04302c3-e6b8-52d5-b731-49cb72445e0b","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"f67b0001-2425-54d5-9b64-eb5b26e89c1f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"8bb47847-a47c-58eb-9192-d93b3777346c","slug":"topical-salicylic-acid","fullItemName":"Topical salicylic acid"},{"id":"1ecb735e-238a-57cb-b532-d710b9f2e002","slug":"cryotherapy","fullItemName":"Cryotherapy"}]},{"id":"06f21bf2-35a6-5592-8b0c-73f080fb2cf8","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"d30d619e-9d73-5c8c-9449-24ee8f5eb0b7","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"42814eed-7b19-5193-92df-c3b19fa1ecb5","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"5914a980-373d-52ac-bb3e-7aa97407615c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"557d529c-023b-5433-9374-ab45af805fa2","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"315a48c5-bbb5-5396-af46-144bdc7ec32c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f1cfd4d2-5aed-5b67-b68e-89473182c34a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a851a32d-5d5b-5ff8-b194-52d6f3fa1861","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"10a2f64f-ff47-5af9-ae2f-100bfb8e7573","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"9aad0942-646a-52dd-a7ad-ae4fd3148071","slug":"decision-to-treat","fullItemName":"Decision to treat","depth":3,"htmlHeader":"<!-- begin field 9856016f-0eca-44f4-b1a1-b3fb371274fc --><h3>Should warts and verrucae be treated?</h3><!-- end field 9856016f-0eca-44f4-b1a1-b3fb371274fc -->","summary":null,"htmlStringContent":"<!-- begin item ab8edcb1-3d5d-41bd-8523-d71092287629 --><!-- begin field 4f6c3be5-e8f5-4d71-9f22-739ef9a2e6cf --><ul><li><strong>For most people there is a strong case for not treating warts or verrucae.</strong><ul><li>Cutaneous warts do not usually cause symptoms and in most cases resolve spontaneously within months or, at the most, within 2 years. However, sometimes in adults resolution may take 5–10 years.</li><li>Treatment may be prolonged and can have adverse effects.<ul><li>Cryotherapy requires several treatments, can be painful at the time of application, and may cause pain, blistering, infection, scarring, and depigmentation.</li><li>Topical salicylic acid may require administration for up to 12 weeks and can cause local skin irritation.</li></ul></li></ul></li><li><strong>Consider treatment if:</strong><ul><li>The wart is painful (for example on the soles of the feet or near the nails).</li><li>The wart is cosmetically unsightly (for example on the hands or face).</li><li>The person requests treatment, and the wart is persisting.</li></ul></li></ul><!-- end field 4f6c3be5-e8f5-4d71-9f22-739ef9a2e6cf --><!-- end item ab8edcb1-3d5d-41bd-8523-d71092287629 -->","subChapters":[{"id":"76a3edcf-bfb1-51da-80eb-02669ff995c3","slug":"basis-for-recommendation-dea","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 09615fc9-de33-49f0-b784-cf7e4fa50117 --><h4>Basis for recommendation</h4><!-- end field 09615fc9-de33-49f0-b784-cf7e4fa50117 -->","summary":null,"htmlStringContent":"<!-- begin item deaf9dce-d868-4651-b830-50c10b881239 --><!-- begin field acc32098-1a6a-436c-9f78-1e8795ef0e52 --><p>These recommendations are largely based on expert opinion in clinical guidelines <em>The British Association of Dermatologists' guidelines for the management of cutaneous warts</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>] and <em>Warts</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Primary Care Dermatology Society, 2019</a>], a dermatology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2016a</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2016b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Akram, 2019</a>].</p><h5>No treatment needed</h5><ul><li>The British Association of Dermatologists (BAD) state that for people who are immunocompetent an expectant approach to management is entirely acceptable.</li><li>The information on spontaneous resolution is taken from an observational study in Dutch school children (n = 366) that found that (with and without treatment) half of all warts had resolved after 1 year and two-thirds by 2 years [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Bruggink, 2013</a>].</li><li>The information that in some adults wart clearance may take up to 5–10 years is based on expert opinion in clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>].</li></ul><!-- end field acc32098-1a6a-436c-9f78-1e8795ef0e52 --><!-- end item deaf9dce-d868-4651-b830-50c10b881239 -->","subChapters":[]}]},{"id":"667631f1-dde8-5b3a-838c-4bcffd9db2ee","slug":"choice-of-treatment","fullItemName":"Choice of treatment","depth":3,"htmlHeader":"<!-- begin field dcf6770c-3d58-4752-b3fa-499f012f6eea --><h3>Which treatments are recommended in primary care for warts or verrucae?</h3><!-- end field dcf6770c-3d58-4752-b3fa-499f012f6eea -->","summary":null,"htmlStringContent":"<!-- begin item 02c308c9-7a71-4191-9d8e-1344f1aa628c --><!-- begin field 9acc106f-67c9-486c-bf35-1e902b1861c4 --><ul><li><strong>Facial warts should not routinely be treated in primary care</strong> — <a class=\"topic-reference internal-reference\" href=\"/topics/warts-verrucae/management/management/#referral\">refer to dermatology</a> if treatment is indicated.</li><li><strong>For non-facial warts:</strong><ul><li><strong>For adults and older children,</strong> treatment depends upon what has been tried already and what the person prefers. Options include:<ul><li>Topical salicylic acid (15–50%) applied daily for up to 12 weeks. For more information see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/warts-verrucae/prescribing-information/topical-salicylic-acid/\">Topical salicylic acid</a>.</li><li>Cryotherapy with liquid nitrogen (usually carried out every 2 weeks until the wart is gone, up to a maximum of six treatments). Note, cryotherapy is only suitable for some older children who are likely to tolerate this treatment. For more information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/warts-verrucae/prescribing-information/cryotherapy/\">Cryotherapy</a>.</li><li>Combination therapy with salicylic acid and cryotherapy (applying topical salicylic acid preparations between cryotherapy sessions once the scabbing from cryotherapy has resolved).</li><li>A shorter cryotherapy freeze (for example 5–10 seconds) or a weaker strength topical salicylic acid preparation (for example 17% or less) is recommended for plane warts on the back of the hands, as scarring is more likely to occur.</li><li>Plantar warts are difficult to treat and cryotherapy is unlikely to help — as pain caused by plantar warts is usually due to thickening of the skin regular paring can help make the feet more comfortable. Care should be taken when paring to avoid abrading the surrounding normal skin, as this may lead to spread.</li></ul></li><li><strong>For younger children</strong>, offer treatment with topical salicylic acid applied daily for up to 12 weeks.<ul><li>For more information see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/warts-verrucae/prescribing-information/topical-salicylic-acid/\">Topical salicylic acid</a>.</li><li>Do not use cryotherapy in younger children.</li></ul></li></ul></li></ul><!-- end field 9acc106f-67c9-486c-bf35-1e902b1861c4 --><!-- end item 02c308c9-7a71-4191-9d8e-1344f1aa628c -->","subChapters":[{"id":"663fbdad-0ada-5136-8b0d-9e61d752334b","slug":"basis-for-recommendation-146","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 62bf92ed-9959-40cb-bd4a-0ba9b047173b --><h4>Basis for recommendation</h4><!-- end field 62bf92ed-9959-40cb-bd4a-0ba9b047173b -->","summary":null,"htmlStringContent":"<!-- begin item 146bc8a7-5e28-47c9-9483-6d692ee4cccd --><!-- begin field 25d6b6fd-ea7e-4ef5-9858-ba35473cc48e --><p>These recommendations are based on guidance published by the British Association of Dermatologists (BAD) <em>British Association of Dermatologists' guidelines for the management of cutaneous warts</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>] and the Primary Care Dermatological Society (PCDS) <em>Warts</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Primary Care Dermatology Society, 2019</a>], a dermatology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2016a</a>], a Cochrane systematic review <em>Topical treatments for cutaneous warts</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Kwok, 2012</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Miller, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Ockenfels, 2016</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2016b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Akram, 2019</a>].</p><p><strong>Not treating facial warts in primary care</strong> — CKS recommend that facial warts should not be routinely treated in primary care because:</p><ul><li>There is a risk that treatment with salicylic acid or cryotherapy with liquid nitrogen may cause severe irritation and possible scarring [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Primary Care Dermatology Society, 2019</a>].</li><li>Treatment with topical salicylic acid is contraindicated for use on the face [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">BNF, 2019</a>].</li></ul><h5><strong>Topical salicylic acid</strong></h5><ul><li>The recommendation on use of salicylic acid in the treatment of warts is based on expert opinion from BAD [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>], the PCDS [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Primary Care Dermatology Society, 2019</a>], a dermatology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2016a</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Miller, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Ockenfels, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Akram, 2019</a>].</li><li>A Cochrane review of topical treatments for skin warts (85 trials, n = 8,815) found that salicylic acid significantly increased the chance of clearance of warts (RR 1.56, 95% CI 1.20 to 2.03) compared with placebo. Subgroup analysis suggested salicylic acid may be more effective on the hands (RR 2.67, 95% CI 1.43 to 5.01) compared with the feet (RR 1.29, 95% CI 1.07 to 1.55). Meta‐analysis did not identify a significant difference in effectiveness between cryotherapy and salicylic acid at any site (RR 1.23, 95% CI 0.88 to 1.71) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Kwok, 2012</a>].</li><li>BAD recommend using a topical salicylic acid preparation of between 15–40%. CKS found insufficient evidence to recommend any particular salicylic acid preparation over another and have also included the commercially available 50% salicylic acid preparation as BAD cited a single study showing evidence for its efficacy.</li></ul><h5>Cryotherapy with liquid nitrogen</h5><ul><li>The recommendation to use cryotherapy to treat cutaneous warts is based on expert opinion in guidance from BAD [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>] and the PCDS [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Primary Care Dermatology Society, 2019</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Miller, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Ockenfels, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Akram, 2019</a>]. Weak evidence from a Cochrane review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Kwok, 2012</a>] reported:<ul><li>No significant difference between treatment with cryotherapy and placebo or no treatment.</li><li>No significant difference between treatment with cryotherapy and topical salicylic acid.</li><li>Aggressive cryotherapy was significantly more effective than gentle cryotherapy, however, there were significantly more adverse effects with aggressive cryotherapy.</li></ul></li><li>The information on treatment of plantar warts is taken from PCDS guidance that recommends that only in exceptional circumstances should patients receive cryotherapy for plantar warts as it is unlikely to help and is associated with adverse effects such as blistering and pain [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Primary Care Dermatology Society, 2019</a>].</li></ul><h5>Combining salicylic acid and cryotherapy</h5><ul><li>The recommendations to use combined treatment with salicylic acid and cryotherapy is based on expert opinion from BAD [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>] and the PCDS [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Primary Care Dermatology Society, 2019</a>], and evidence from a Cochrane review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Kwok, 2012</a>]. This Cochrane review identified evidence from two randomized controlled trials (n = 328) that found that compared with topical salicylic acid, treatment with topical salicylic acid plus cryotherapy was significantly more effective (RR 1.24, 95% CI 1.07 to 1.43).</li><li>The recommendation to perform cryotherapy every 2 weeks for up to 3–4 months is based on expert opinion from BAD. A Cochrane review found no significant difference in cure rates between cryotherapy at 2, 3, or 4-weekly intervals [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Kwok, 2012</a>].</li></ul><h5>Milder freeze or weaker strength topical salicylic acid for plane warts on the back of the hands</h5><ul><li>This recommendation is based on expert opinion from BAD [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>].</li></ul><h5>Cryotherapy for younger children</h5><ul><li>CKS do not recommend cryotherapy for younger children because they may find it too painful and may not be able to keep still long enough for the treatment to be applied. In addition evidence on effectiveness is limited.</li></ul><h5>Treatments not recommended</h5><ul><li>Occlusion (for example duct tape) therapy and treatment with silver nitrate are not recommended because BAD found insufficient evidence that these treatments were effective for warts [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2016b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Akram, 2019</a>].</li></ul><!-- end field 25d6b6fd-ea7e-4ef5-9858-ba35473cc48e --><!-- end item 146bc8a7-5e28-47c9-9483-6d692ee4cccd -->","subChapters":[]}]},{"id":"927e1c2c-9844-56bc-8537-1a2c3a5d5150","slug":"referral","fullItemName":"Referral","depth":3,"htmlHeader":"<!-- begin field e1be2fe5-0059-4bcd-8d75-61591c288767 --><h3>When should I refer someone with warts or verrucae?</h3><!-- end field e1be2fe5-0059-4bcd-8d75-61591c288767 -->","summary":null,"htmlStringContent":"<!-- begin item 4ceee3ae-664e-499c-9c06-4992ea0090e8 --><!-- begin field 61489435-11af-4f7e-832f-0ea1e3ef3459 --><ul><li>In general, most warts can be managed in primary care. Specialized treatments may be available in secondary care dependent on local referral guidelines.</li><li>Consider referral to a dermatologist, if:<ul><li>The person has a facial wart.</li><li>The diagnosis is uncertain.</li><li>The person is immunocompromised.</li><li>The person has areas of skin that are extensively affected, for example, mosaic warts of the hands and feet.</li><li>The person is bothered by persistent warts that are unresponsive to both topical salicylic acid and cryotherapy, if indicated.</li></ul></li></ul><!-- end field 61489435-11af-4f7e-832f-0ea1e3ef3459 --><!-- end item 4ceee3ae-664e-499c-9c06-4992ea0090e8 -->","subChapters":[{"id":"dfd44d31-fd18-56e1-99d8-801025ce5abb","slug":"treatment-options-in-secondary-care","fullItemName":"Treatment options in secondary care","depth":4,"htmlHeader":"<!-- begin field a79929af-8dcd-42ca-8351-977f5e6c891d --><h4>Treatment options in secondary care</h4><!-- end field a79929af-8dcd-42ca-8351-977f5e6c891d -->","summary":null,"htmlStringContent":"<!-- begin item 87399074-187f-480b-ae6c-3ba12c46cd7b --><!-- begin field b75db683-2f07-4a7b-b03d-6ac27c1abcb4 --><ul><li>Treatment options available in secondary care may include:<ul><li>Physical ablation, such as surgery, laser treatment, and photodynamic treatment.</li><li>Antimitotic treatments, such as topical podophyllotoxin, topical or oral retinoids, or intralesional bleomycin.</li><li>Immunomodulatory treatments, such as topical sensitizers (such as squaric acid dibutylester), topical imiquimod 5%, or intralesional interferon.</li><li>Virucidal treatments, such as formaldehyde and glutaraldehyde.</li><li>Cantharidin (a potent blistering agent extracted from blister beetles) may be available in some secondary care departments.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Ahn, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Lynch, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Ockenfels, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Akram, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">CADTH, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Primary Care Dermatology Society, 2019</a>]</p><!-- end field b75db683-2f07-4a7b-b03d-6ac27c1abcb4 --><!-- end item 87399074-187f-480b-ae6c-3ba12c46cd7b -->","subChapters":[]},{"id":"9e15bda5-d1a9-5b35-85cd-77b38d8d331b","slug":"basis-for-recommendation-a75","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field eaa5e205-a65c-40e3-8a8e-55d1cf940ef8 --><h4>Basis for recommendation</h4><!-- end field eaa5e205-a65c-40e3-8a8e-55d1cf940ef8 -->","summary":null,"htmlStringContent":"<!-- begin item a7509bd3-5117-4afc-aa23-909047edb4cb --><!-- begin field b9d878a6-62ec-4ab2-8a6a-f6aa7dc78d3d --><p>Referral criteria will ultimately depend upon local recommendations. The suggested indications for referral are based on expert opinion in guidelines published by the British Association of Dermatologists (BAD) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>], review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Lynch, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Akram, 2019</a>], and widely accepted good clinical practice.</p><h5>Facial warts</h5><ul><li>CKS recommends that facial warts should not be routinely treated in primary care because:<ul><li>There is a risk that treatment with salicylic acid or cryotherapy with liquid nitrogen may cause severe irritation and possible scarring [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>].</li><li>Treatment with topical salicylic acid is specifically contraindicated for use on the face [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">BNF, 2019</a>].</li></ul></li></ul><!-- end field b9d878a6-62ec-4ab2-8a6a-f6aa7dc78d3d --><!-- end item a7509bd3-5117-4afc-aa23-909047edb4cb -->","subChapters":[]}]},{"id":"4ec1637d-65e8-5bcf-9252-50d4081c82dd","slug":"advice","fullItemName":"Advice","depth":3,"htmlHeader":"<!-- begin field 27e76078-f2b4-43d1-8a6e-f57c1700fb9a --><h3>What advice should I give to someone with warts or verrucae?</h3><!-- end field 27e76078-f2b4-43d1-8a6e-f57c1700fb9a -->","summary":null,"htmlStringContent":"<!-- begin item 93ede71b-50b9-438c-a7ca-cad2db50757e --><!-- begin field db6fa4a8-c3ae-44ef-9c79-36ffc419fd9d --><ul><li>Advise that:<ul><li>Although warts can be cosmetically unsightly, they are not harmful; usually they do not cause symptoms and resolve without treatment.</li><li>Warts are contagious, but the risk of transmission is thought to be low.</li><li>To reduce the risk of transmission:<ul><li>Cover the wart with a waterproof plaster when swimming. The Amateur Swimming Association (ASA) states that the use of swimming socks should be discouraged and that a waterproof plaster is sufficient.</li><li>Wear flip-flops or other appropriate footwear in communal showers.</li><li>Avoid sharing shoes, socks, or towels.</li></ul></li><li>In order to limit personal spread (auto-inoculation):<ul><li>Avoid scratching lesions.</li><li>Avoid biting nails or sucking fingers that have warts.</li><li>Keep feet dry and change socks daily.</li></ul></li><li>Children with warts or verrucae should not be excluded from activities, such as sports and swimming, but should take care to minimize transmission.</li><li>Provide patient information, such as:<ul><li><a href=\"http://www.bad.org.uk/shared/get-file.ashx?id=176&itemtype=document\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"5db2503e-6fb5-4f2c-afc3-ab7200a820f4\">Plantar warts (verrucas)</a> from the British Association of Dermatologists.</li><li><a href=\"http://www.nhs.uk/conditions/warts-and-verrucas/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"938ae7db-ce58-42de-af4e-ab7200a8211b\">Warts and verrucas</a> from the NHS.</li><li><a href=\"http://www.bad.org.uk/shared/get-file.ashx?id=192&itemtype=document.\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"d9b4e23a-d6f0-4fcf-a5ae-ab7200a82137\">Cryotherapy</a> from the British Association of Dermatologists.</li></ul></li></ul></li></ul><!-- end field db6fa4a8-c3ae-44ef-9c79-36ffc419fd9d --><!-- end item 93ede71b-50b9-438c-a7ca-cad2db50757e -->","subChapters":[{"id":"d729214b-dd34-5760-bd4e-aa6589070720","slug":"basis-for-recommendation-9a7","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 1954df7f-d001-4183-abdb-17ef7a73105a --><h4>Basis for recommendation</h4><!-- end field 1954df7f-d001-4183-abdb-17ef7a73105a -->","summary":null,"htmlStringContent":"<!-- begin item 9a799f69-f3fe-4601-aab0-cef647334d4c --><!-- begin field 40263b1a-45eb-4b3b-a7cc-9b933e97ccfc --><p>The advice to people with warts and verrucae are based on expert opinion in clinical guidelines <em>Warts</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Primary Care Dermatology Society, 2019</a>], a dermatology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2016a</a>], and patient information leaflets published by the British Association of Dermatologists [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">BAD, 2012</a>], and the Amateur Swimming Association British Swimming [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">British Swimming, 2014</a>].</p><!-- end field 40263b1a-45eb-4b3b-a7cc-9b933e97ccfc --><!-- end item 9a799f69-f3fe-4601-aab0-cef647334d4c -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}